978 related articles for article (PubMed ID: 25178934)
1. Myeloid regulatory cells in tumor spreading and metastasis.
Keskinov AA; Shurin MR
Immunobiology; 2015 Feb; 220(2):236-42. PubMed ID: 25178934
[TBL] [Abstract][Full Text] [Related]
2. The metastasis-promoting roles of tumor-associated immune cells.
Smith HA; Kang Y
J Mol Med (Berl); 2013 Apr; 91(4):411-29. PubMed ID: 23515621
[TBL] [Abstract][Full Text] [Related]
3. Myeloid cells in cancer-related inflammation.
Caronni N; Savino B; Bonecchi R
Immunobiology; 2015 Feb; 220(2):249-53. PubMed ID: 25454487
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells.
Bianchi G; Borgonovo G; Pistoia V; Raffaghello L
Histol Histopathol; 2011 Jul; 26(7):941-51. PubMed ID: 21630223
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory chemokines and metastasis--tracing the accessory.
Borsig L; Wolf MJ; Roblek M; Lorentzen A; Heikenwalder M
Oncogene; 2014 Jun; 33(25):3217-24. PubMed ID: 23851506
[TBL] [Abstract][Full Text] [Related]
6. Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis.
Ye XZ; Yu SC; Bian XW
J Genet Genomics; 2010 Jul; 37(7):423-30. PubMed ID: 20659706
[TBL] [Abstract][Full Text] [Related]
7. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
8. Newly recruited CD11b+, GR-1+, Ly6C(high) myeloid cells augment tumor-associated immunosuppression immediately following the therapeutic administration of oncolytic reovirus.
Clements DR; Sterea AM; Kim Y; Helson E; Dean CA; Nunokawa A; Coyle KM; Sharif T; Marcato P; Gujar SA; Lee PW
J Immunol; 2015 May; 194(9):4397-412. PubMed ID: 25825443
[TBL] [Abstract][Full Text] [Related]
9. Myeloid Cells in Metastasis.
Swierczak A; Pollard JW
Cold Spring Harb Perspect Med; 2020 May; 10(5):. PubMed ID: 31548218
[TBL] [Abstract][Full Text] [Related]
10. Myeloid-derived suppressor cells in malignant melanoma.
Umansky V; Sevko A; Gebhardt C; Utikal J
J Dtsch Dermatol Ges; 2014 Nov; 12(11):1021-7. PubMed ID: 25263083
[TBL] [Abstract][Full Text] [Related]
11. The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins?
Brandau S; Moses K; Lang S
Semin Cancer Biol; 2013 Jun; 23(3):171-82. PubMed ID: 23459190
[TBL] [Abstract][Full Text] [Related]
12. Melanoma-induced immunosuppression and its neutralization.
Umansky V; Sevko A
Semin Cancer Biol; 2012 Aug; 22(4):319-26. PubMed ID: 22349515
[TBL] [Abstract][Full Text] [Related]
13. TNF Receptor-2 Facilitates an Immunosuppressive Microenvironment in the Liver to Promote the Colonization and Growth of Hepatic Metastases.
Ham B; Wang N; D'Costa Z; Fernandez MC; Bourdeau F; Auguste P; Illemann M; Eefsen RL; Høyer-Hansen G; Vainer B; Evrard M; Gao ZH; Brodt P
Cancer Res; 2015 Dec; 75(24):5235-47. PubMed ID: 26483205
[TBL] [Abstract][Full Text] [Related]
14. Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells.
Peyvandi S; Buart S; Samah B; Vétizou M; Zhang Y; Durrieu L; Polrot M; Chouaib S; Benihoud K; Louache F; Karray S
Cancer Res; 2015 Oct; 75(20):4292-301. PubMed ID: 26359460
[TBL] [Abstract][Full Text] [Related]
15. The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells.
Wang J; De Veirman K; De Beule N; Maes K; De Bruyne E; Van Valckenborgh E; Vanderkerken K; Menu E
Oncotarget; 2015 Dec; 6(41):43992-4004. PubMed ID: 26556857
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-Derived Suppressor Cells and Proinflammatory Cytokines as Targets for Cancer Therapy.
Atretkhany KN; Drutskaya MS
Biochemistry (Mosc); 2016 Nov; 81(11):1274-1283. PubMed ID: 27914453
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected.
Marvel D; Gabrilovich DI
J Clin Invest; 2015 Sep; 125(9):3356-64. PubMed ID: 26168215
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia and the Metastatic Niche.
Chan CY; Yuen VW; Wong CC
Adv Exp Med Biol; 2019; 1136():97-112. PubMed ID: 31201719
[TBL] [Abstract][Full Text] [Related]
19. HPV16-associated tumors control myeloid cell homeostasis in lymphoid organs, generating a suppressor environment for T cells.
Stone SC; Rossetti RA; Bolpetti A; Boccardo E; Souza PS; Lepique AP
J Leukoc Biol; 2014 Oct; 96(4):619-31. PubMed ID: 24970861
[TBL] [Abstract][Full Text] [Related]
20. The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases.
Hussain S; Peng B; Cherian M; Song JW; Ahirwar DK; Ganju RK
Front Immunol; 2020; 11():598532. PubMed ID: 33414786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
